Orlistat blocks fat absorption in the gut
Forecasting Methods Time-series modelling S-curve and diffusion models (for emerging technologies) Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes) Price elasticity models Market maturity and lifecycle-based projections Scenario Analysis Given inherent uncertainties, three scenarios were constructed: Base-Case Scenario: Expected trajectory under current conditions Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds Conservative Scenario: Slow adoption, regulatory delays, economic constraints Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption
The dose-response curve for Retatrutide is linear: 1mg (8.7% loss), 4mg (15.2%), 8mg (21.1%), 12mg (24.2%)
Compounded copies have been a recurring regulatory fight, including last week's FDA warning letter to Gram Peptides that named retatrutide explicitly